BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 33760216)

  • 21. Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/ FSTL1 signal pathway.
    Hu Z; Zhao P; Zhang K; Zang L; Liao H; Ma W
    Arch Biochem Biophys; 2020 May; 685():108353. PubMed ID: 32234499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.
    Ye J; Feng JW; Wu WX; Qi GF; Wang F; Hu J; Hong LZ; Liu SY; Jiang Y
    J Endocrinol Invest; 2023 Mar; 46(3):509-522. PubMed ID: 36115894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spleen tyrosine kinase facilitates the progression of papillary thyroid cancer regulated by the hsa_circ_0006417/miR-377-3p axis.
    Tan G; Zheng S; Zhou B; Mo Z; Zhang Q; Zhang D; Li A; Liu X
    Environ Toxicol; 2024 Jan; 39(1):421-434. PubMed ID: 37792549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis.
    Zhang Z; Mo Y; Wu L; Wang X; Liao G; Tan W; Li D
    Anticancer Drugs; 2022 Oct; 33(9):923-934. PubMed ID: 36136992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells.
    Zhang C; Gu H; Liu D; Tong F; Wei H; Zhou D; Fang J; Dai X; Tian H
    Mol Cell Biochem; 2022 Nov; 477(11):2627-2641. PubMed ID: 35598218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_LDLR promotes the progression of papillary thyroid carcinoma by regulating miR-1294/HMGB3 axis.
    Chen G; Han P; Zhang Q; Li M; Song T; Chen Z; Zhao Y; Yin D; Lv J
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23498. PubMed ID: 37565296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
    Lan X; Cao J; Xu J; Chen C; Zheng C; Wang J; Zhu X; Zhu X; Ge M
    J Clin Lab Anal; 2018 Oct; 32(8):e22573. PubMed ID: 29790216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
    Shen J; Ma Z; Yang J; Qu T; Xia Y; Xu Y; Zhou M; Liu W
    BMC Cancer; 2024 Apr; 24(1):511. PubMed ID: 38654205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer.
    Dai L; Hu W; Jiang H; Wang Y; Le Q; Wu X; Meng X
    Int J Clin Oncol; 2023 Nov; 28(11):1461-1474. PubMed ID: 37568034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. circ_0067934 promotes the progression of papillary thyroid carcinoma cells through miR-1301-3p/HMGB1 axis.
    Dong LP; Chen LY; Bai B; Qi XF; Liu JN; Qin S
    Neoplasma; 2022 Jan; 69(1):1-15. PubMed ID: 34704451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304.
    Pan Y; Xu T; Liu Y; Li W; Zhang W
    Biochem Biophys Res Commun; 2019 Mar; 510(2):334-338. PubMed ID: 30709584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway.
    Wang M; Chen B; Ru Z; Cong L
    Biochem Biophys Res Commun; 2018 Sep; 504(1):283-288. PubMed ID: 30190130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1
    Li P; Chen J; Zou J; Zhu W; Zang Y; Li H
    Bioengineered; 2022 Mar; 13(3):7181-7196. PubMed ID: 35264065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsa_circ_0017639 expression promotes gastric cancer proliferation and metastasis by sponging miR-224-5p and upregulating USP3.
    Li B; Jin M; Cao F; Li J; Wu J; Xu L; Liu X; Shi Y; Chen W
    Gene; 2020 Aug; 750():144753. PubMed ID: 32376451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis.
    Zhu J; Wang Y; Yang C; Feng Z; Huang Y; Liu P; Chen F; Deng Z
    J Recept Signal Transduct Res; 2022 Jun; 42(3):251-260. PubMed ID: 33858297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
    Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
    Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
    Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.